Blood· 2013Q1

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus et al.

1,992citations
Q1SCImago
2013year

Short summary

Updated 2013 European LeukemiaNet guidelines recommend imatinib, nilotinib, or dasatinib as initial treatment for chronic myeloid leukemia (CML), with response assessed by molecular and cytogenetic markers at 3, 6, and 12 months.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hematology

HematologyMedicine